medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2010, Number 4

<< Back

Rev Invest Clin 2010; 62 (4)

Pharmacological treatment of diabetic neuropathy in the elderly

Mimenza-Alvarado A, Aguilar-Navarro S

Language: Spanish
References: 31
Page: 375-383
PDF size: 77.56 Kb.


ABSTRACT

Diabetic neuropathy is the third most common complication of diabetes mellitus. When this neuropathy is accompanied by pain, requires a specific treatment. In the elderly patient, the pain has an enormous impact on quality of life, as it is associated with anxiety, depression and sleep disorders, leading to a direct impact on the functionality of the patient. Likewise, there are a number of changes at the central and peripheral nervous system, which contribute to the chronicity of painful processes, and eventually also affect and impact on the quality of life of elderly patients. It is fundamental before to initiating treatment, to know of all aspects related to drug pharmacokinetics and pharmacodynamics, especially those related to which are also involved in aging, because this will neuromodulator, allow you to select the best drug for each patient. This article aims to review the pathophysiological concepts related to diabetic neuropathy in the elderly and the best treatment options.


REFERENCES

  1. Harati Y. Diabetic Neuropathies: Unanswered questions. Neurol Clin 2007; 25: 303-17.

  2. Vinik AI, Strotmeyer ES, Nakave AA, et al. Diabetic neuropathy in older adults. Clin Geriatr Med 2008; 24: 407-35.

  3. Barkin RL, Barkin SJ, Barkin DS. Pharmacotherapeutic Management of pain with a focus directed at the geriatric patient. Rheum Dis Clin N Am 2007; 33: 1-31.

  4. Katz B, Helme RD. Pain problems in old age. In: Tallis R, Fillit H, Brocklehurst JC, editors. Brocklehurst´s textbook of geriatric medicine and gerontology. London: Harcourt Brace; 1998.

  5. Bruckental P. Assessment pf pain in the elderly adult. Clin Geriatr Med 2008; 24: 213-36.

  6. Nagda J, Bajwa ZH. In Warfieldn CA, Bajwa ZH. Principles and Practice of Pain Medicine. United States of America: McGraw-Hill; 2004.

  7. Merskey H, Bogduk N. Classification of chronic pain. Seattle: IASP Press, 1994.

  8. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-5.

  9. Boulton AJM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes care 2004; 27: 1458-86.

  10. Unger J, Cole BE. Recognition and management of diabetic neuropathy. Prim Care Clin Office Pract 2007; 34: 887-913.

  11. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain. Diabetes care 2008; 31(Suppl 2): S255-S261.

  12. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288: 1765-8.

  13. Woolf CF. Central sensitization. Uncovering the relation between pain and plasticity. Anesthesiology 2007; 106: 864-7.

  14. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl Med 2003; 348: 1243-55.

  15. Mimenza AJ, Muñiz JC, Estañol B. Neuropatías dolorosas: fisiopatología y tratamiento. Rev Neurol 2004; 39: 364-70.

  16. Bedlack RS, Edelman D, Gibbs JW, et al. APOE genotype is a risk factor for neuropathy severity in diabetic patients. Neurology 2003; 60: 1022-4.

  17. Bedlack RS, Strittmatter WJ, MorgenlanderJC. Apolipoprotein E and neuromuscular disease. Arch Neurol 2000; 57: 1561-5.

  18. Stephens JW, Dhamrait SS, Acharya J, et al. A common variant in the ACE gene is associated with peripheral neuropathy in women with type 2 diabetes mellitus. J Diabetes Complications 2006; 20: 317-21.

  19. Sivenius K, Niskanen L, Voutilainen-Kaumisto R, et al. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Diabet Med 2004; 21: 1325-33.

  20. McCleane G. Pain perception in the elderly patient. Clin Geriatr Med 2008; 24: 203-11.

  21. Verdu E, Ceballos D, Vilches JJ. Influence of aging on peripheral nerve function and regeneration. J Peripher Ner System 2000; 5: 191-208.

  22. Gómez-Pérez FJ, Pérez Monteverde A, Nascimiento O, Aschner P, Tagle M, Fichtner K, et al. Gabapentin for the treatment of painful diabetic neuropathy: Titration to effect is superior to a commonly used fixed dose. BJ Diabet Vasc Dis 2004; 4(3): 173-8.

  23. Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus Guidelines: treatment planning and options. Mayo Clin Proc 2006; 81: S12-S26.

  24. American Diabetes Association. Standars of medical care in diabetes- 2009. Diabetes Care 2009; 32(Suppl 1): S13-61.

  25. Weiner D. Office management of chronic pain in the elderly. Am J Med 2007; 120: 306-15.

  26. Freeman R, Durso-DeCruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy. Findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008; 31: 1448-54.

  27. Backonja M, Beydoun A, Edwards R, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831-6.

  28. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduced diabetic neuropathy: a randomized, controlled study. Neurology 2001; 57: 505-9.

  29. Song XS, Huang ZJ, Song XJ. Thiamine suppresses thermal hyperalgesia, inhibits hyperexcitability and lessens alterations of sodium currents in injured, dorsal roort ganglion neurons in rats. Anesthesiology 2009; 110: 387-400.

  30. Reyes GG, Caram SL, Medina SR,et al. Oral administration of B vitamins increases the antiallodynic effect of gabapentin in the rat. Proc West Pharmacol Soc 2004; 47: 76-9.

  31. Medina SR, Morales FG, Espinoza RJ, et al. Treatment of diabetic neuropathic pain with gabapentin alone or combined with vitamin b complex. Preliminary results. Proc West Pharmacol Soc 2004; 47: 109-12.




2020     |     www.medigraphic.com